Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery

NCT07351149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-05-12

No results posted yet for this study

Summary

This project aims to conduct an international, prospective, multicentre, observational study to determine the incidence of Postoperative Acute Kidney Injury (PO-AKI) in hospitalized children after noncardiac surgery. Urinary biomarkers are intended to be evaluated as predictors of PO-AKI in the same subjects. The study employs modern standardized classifications for AKI to comprehensively address the issue of PO-AKI in children. Describing the incidence and identifying risk factors for PO-AKI will play a crucial role in developing preventive strategies aimed at reducing associated mortality and morbidity. Furthermore, investigating the relationship between urinary biomarkers of renal injury and PO-AKI will provide valuable insights into assessing postoperative renal function in paediatric patients, especially when repeated blood sampling is not feasible.

Conditions

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Skane University Hospital

    collaborator OTHER
  • Karolinska University Hospital

    collaborator OTHER
  • Istituto Giannina Gaslini

    collaborator OTHER
  • Queen Silvia Children's Hospital, Gothenburg, Sweden

    collaborator OTHER
  • Feculdade de Medicina da Universidade de Sao Paulo - Brasil

    collaborator OTHER
  • University of Belgrade

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    collaborator OTHER
  • Hospices Civils de Lyon

    collaborator OTHER
  • University of Bern

    collaborator OTHER
  • University Hospital, Geneva

    collaborator OTHER
  • Child and Adolescent Health Service - Perth

    collaborator OTHER_GOV
  • Uppsala University

    lead OTHER

Principal Investigators

  • Robert Frithiof, MD, PhD · Uppsala University Hospital, Uppsala, Sweden

Eligibility

Min Age
0 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Australia
  • Brazil
  • France
  • Italy
  • Serbia
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07351149 on ClinicalTrials.gov